Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stanek

Showing results (221-230 of 302) with videos related to

Pageof 31
Sort By:
Statistics & Probability Letters|December 14, 2011
Prediction with measurement errors in finite populationsJulio M Singer, Edward J Stanek, Viviana B Lencina, et al.
Facial Plastic Surgery : FPS|July 29, 2005
Laser techniques associated with facial aesthetic and reparative surgeryM A Trelles, P Brychta, J Stanek, et al.
Ginekologia Polska|January 1, 1979
[Usefulness of the Nesbitt-Aubry scale for the evaluation of the effect of harmful factors on the course of pregnancy]R Klimek, A Bacz, M Chlamtasch-Ksiezyk, et al.
Clinical Therapeutics|March 24, 2007
Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?Chaitanya A Sarawate, Mark J Cziraky, Eric J Stanek, et al.
The American Journal of Cardiology|January 15, 1994
Arterial oxygen saturation in chronic congestive heart failureM A Munger, E J Stanek, A R Nara, et al.
Medicine and Science in Sports and Exercise|May 5, 2000
Comparing physical activity assessment methods in the Seasonal Variation of Blood Cholesterol StudyC E Matthews, P S Freedson, J R Hebert, et al.
The Journal of Biological Chemistry|December 15, 2010
Deacetylation of the DNA-binding domain regulates p53-mediated apoptosisHestia S Mellert, Timothy J Stanek, Stephen M Sykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Journal of Clinical Lipidology|February 5, 2011
Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular eventsScott L Charland, Mark J Cziraky, Ralph Quimbo, et al.
Pharmacotherapy|May 1, 1994
Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failureE J Stanek, A R Nara, K P Strohl, et al.
Pageof 31

Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
Statistics & Probability Letters|December 14, 2011
Prediction with measurement errors in finite populationsJulio M Singer, Edward J Stanek, Viviana B Lencina, et al.
Facial Plastic Surgery : FPS|July 29, 2005
Laser techniques associated with facial aesthetic and reparative surgeryM A Trelles, P Brychta, J Stanek, et al.
Ginekologia Polska|January 1, 1979
[Usefulness of the Nesbitt-Aubry scale for the evaluation of the effect of harmful factors on the course of pregnancy]R Klimek, A Bacz, M Chlamtasch-Ksiezyk, et al.
Clinical Therapeutics|March 24, 2007
Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?Chaitanya A Sarawate, Mark J Cziraky, Eric J Stanek, et al.
The American Journal of Cardiology|January 15, 1994
Arterial oxygen saturation in chronic congestive heart failureM A Munger, E J Stanek, A R Nara, et al.
Medicine and Science in Sports and Exercise|May 5, 2000
Comparing physical activity assessment methods in the Seasonal Variation of Blood Cholesterol StudyC E Matthews, P S Freedson, J R Hebert, et al.
The Journal of Biological Chemistry|December 15, 2010
Deacetylation of the DNA-binding domain regulates p53-mediated apoptosisHestia S Mellert, Timothy J Stanek, Stephen M Sykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Journal of Clinical Lipidology|February 5, 2011
Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular eventsScott L Charland, Mark J Cziraky, Ralph Quimbo, et al.
Pharmacotherapy|May 1, 1994
Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failureE J Stanek, A R Nara, K P Strohl, et al.
Pageof 31